Dystonia, characterized by abnormal muscle contractions, presents unique challenges in diagnosis and treatment. This track will focus on the underlying neurological mechanisms that drive dystonia and explore both pharmacological and surgical approaches for managing this condition. Special attention will be given to the role of neurostimulation techniques and the latest advancements in botulinum toxin therapies.
Track 13-1: Pathophysiology of Dystonia
Track 13-2: Advances in Pharmacological Treatments for Dystonia
Track 13-3: Botulinum Toxin in the Treatment of Dystonia
Track 13-4: Surgical Approaches and Deep Brain Stimulation
Track 13-5: Emerging Therapies for Dystonia Management
This track will provide a comprehensive understanding of dystonia’s complexities and how the latest treatments are offering new hope for patients.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
